Navigation Links
Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
Date:4/13/2009

NOVATO, Calif., April 13 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP) today announced the appointment of Patrice P. Rioux, M.D., Ph.D., as Chief Medical Officer ("CMO"). Dr. Rioux will be responsible for the clinical and regulatory advancement of Raptor's clinical-stage drug development programs.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO )

Raptor's clinical programs include Delayed-Release Cysteamine ("DR Cysteamine") for the potential treatment of nephropathic cystinosis ("cystinosis"), non-alcoholic steatohepatitis ("NASH") and Huntington's Disease ("Huntington's"), as well as Convivia(TM), for the potential treatment of aldehyde dehydrogenase ("ALDH2") deficiency.

Dr. Rioux has extensive experience as a clinician, researcher, medical director and regulatory specialist. Most recently, Dr. Rioux was CMO of FerroKin Biosciences, an early-stage developer of iron chelator for treatment of anemias. Prior to that, he was CMO and Vice President Clinical/Regulatory for Edison Pharmaceuticals, which focused on developing drugs to treat inherited and acquired energy impairment diseases. Dr. Rioux' three-decade career includes industry experience at companies such as Repligen Corp., Arrow International, Variagenics, Inc., Biogen and GRP (Groupement de Recherche en Pharmacologie). He previously was a researcher in Clinical Research and Epidemiology at INSERM (Institut National de la Sante et de la Recherche Medicale), a French organization that supports national research in the medical field, from 1975 to 1995. Educated in France, Dr. Rioux has an M.D., a Ph.D. in Mathematical Statisics, and a Masters in Pharmacology.

Christopher M. Starr, Ph.D.,
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
2. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
3. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
4. Raptor Pharmaceuticals Provides Update on Targeting Platforms
5. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
6. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
7. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
8. Raptor Pharmaceuticals Provides Update of Product Programs
9. Strativa Pharmaceuticals Provides Product Pipeline Update
10. Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009
11. Arena Pharmaceuticals to Host Conference Call and Webcast on Monday, March 30, 2009 to Discuss Lorcaserin Pivotal Phase 3 Obesity Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015   Temptime Corporation ... the health care industry, announced today that its board ... Hooff to chief executive officer.  Mr. Van ... Temptime since 2011. "Renaat deeply values Temptime,s ... outstanding job of expanding Temptime,s products and services to ...
(Date:5/5/2015)... 2015  Trovagene, Inc. (NASDAQ:  TROV), a developer ... results for the three months ended March 31, ... we presented favorable clinical results at ASCO GI, ... our Precision Cancer Monitoring platform,s ability to detect ... lung cancers," said Antonius Schuh, Ph.D., chief executive ...
(Date:5/5/2015)... /CNW Telbec/ - Ergoresearch Ltd (TSXV: ERG) ... known under the « Équilibre, orthèses et biomécanique» ... previously announced on April 23, 2015 regarding the acquisition ... Orthoconcept (2008) inc.   The purchase price ... ERG) to the vending shareholder, namely 9211-5096 Québec inc.. ...
Breaking Medicine Technology:Temptime President Renaat Van den Hooff Promoted to CEO 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 4Trovagene, Inc. Announces First Quarter 2015 Financial Results 5Trovagene, Inc. Announces First Quarter 2015 Financial Results 6Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 2Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 3
(Date:5/6/2015)... 2015 When it comes to advice ... reputable and respected than those of a physician. It ... physician lose more weight than those who received no ... by the University of Georgia and published in the ... that patients advised by their physicians dropped more pounds, ...
(Date:5/6/2015)... Launch Corporation, LLC. is pleased to announce that ... at 17 Tanguay Avenue. Owned and operated by Rick Arnold ... location in New England. , “We are extremely excited for ... founder, co-owner and CEO of Launch. “They have established great ... seeing them continue to establish that positive growth in the ...
(Date:5/6/2015)... NC (PRWEB) May 06, 2015 LINET ... Award of Charlotte in the small business category. The ... The Mayor’s International Community Award is given on an ... area that exhibit outstanding contributions to philanthropy. Since ... the Mayor have hosted the Mayor’s International Community Awards. ...
(Date:5/6/2015)... “ Radiation Island ” was featured on ... look at the latest and coolest applications on the market ... AppWatch and technology expert, conducted the app review and shared ... games on iOS. , Touted as one of the best ... by users, which is obvious because of its rating of ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 With ProPoint: Hand ... within Final Cut Pro X . With ProPoint: ... 3D space to further more customize each preset all with ... are given up to 90 fully customizable effect presets all ... circles, curved arrows, straight arrows, underlines, and more. , ...
Breaking Medicine News(10 mins):Health News:Diet Doc Unveils New Protocol Around Doctor Advised Weight Loss 2Health News:Diet Doc Unveils New Protocol Around Doctor Advised Weight Loss 3Health News:Jump Up and Celebrate: Launch Trampoline Park Opens in Nashua, NH 2Health News:LINET Americas Wins The Mayor's International Community Award in Charlotte 2Health News:Top Grossing iPhone Game, Radiation Island, Was Featured on NewsWatch 2Health News:FCPX Plugin Developer Pixel Film Studios release Propoint Hand Drawn 2
... the Long-Term Care market -LISLE, IL, Jan. 5 ... the "Company") (NASDAQ: SXCI , TSX: ... benefit management services, announces that its Health Care ... three-year, multi-million dollar contract to provide its Resident ...
... GUANGZHOU, China, Jan. 5 /PRNewswire-Asia/ -- China Medicine ... Company"), a leading,developer and distributor of prescription and ... and dietary supplements,medical devices and medical formulations, announced ... Investor Relations for a primary term of one ...
... 2008, Laura Plummer made enough New,Year,s resolutions for six ... exercising, ate healthfully, lost 35 pounds, lowered her cholesterol,and ... according to RealAge.com,s,patented test. , ... Winfrey Show" came,calling. On Tuesday, January 6, Plummer will ...
... Lumenis announces 510(k) approval for the new AcuPulse ... Jan. 5 Lumenis Inc., a global ... radiofrequency devices for surgical, aesthetic, and ophthalmic applications, ... of its new AcuPulse CO2 Laser for ENT, ...
... Lark is proud to announce that she is reformulating her squalane skin ... than sharks. , ... Potomac, MD (PRWEB) January 5, 2009 -- Dr. ... skin care line. The new line will contain squalane sourced from olives ...
... services company, outlines the next steps following SSDI denial , ... ... denial letter from the Social Security Administration can be devastating, but ... to Allsup , which represents tens of thousands of people ...
Cached Medicine News:Health News:SXC Health Solutions announces contract with PharMerica 2Health News:China Medicine Renews Contract with CCG Investor Relations 2Health News:China Medicine Renews Contract with CCG Investor Relations 3Health News:Taking 20 Years Off Her Health and Looks, RealAge Member Flaunts It on 'Oprah' Show 2Health News:An Evolution in Automated CO2 Laser Surgery 2Health News:Dr. Susan Lark's Squalane Now Made From Olives, Not Sharks 2Health News:Dr. Susan Lark's Squalane Now Made From Olives, Not Sharks 3Health News:You've Just Been Denied Social Security Disability--Now What? 2Health News:You've Just Been Denied Social Security Disability--Now What? 3Health News:You've Just Been Denied Social Security Disability--Now What? 4
... This model offers all of the ... 2 densitometer with the additional feature ... a small imaging scanner for importing ... immunofixation results or images. This additional ...
Inquire...
... Sebia's Normal and Hypergamma Controls ... on either agarose gels or ... system. Our unique control manufacturing ... as the other serum components, ...
... gel electrophoresis system is designed to ... in classic electrophoresis and immunofixation testing. ... phases of electrophoresis from sample ... staining, destaining and drying. The walkaway ...
Medicine Products: